Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies
- PMID: 38772978
- DOI: 10.1007/s10072-024-07560-2
Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies
Abstract
Introduction: Intracerebral hemorrhage (ICH) is attributable to cerebral small vessel disease (cSVD), which includes cerebral amyloid angiopathy (CAA) and hypertensive-cSVD (HTN-cSVD). HTN-cSVD includes patients with strictly deep ICH/microbleeds and mixed location ICH/microbleeds, the latter representing a more severe form of HTN-cSVD. We test the hypothesis that more severe forms of HTN-cSVD are related to worse hypertension control in long-term follow-up after ICH.
Methods: From consecutive non-traumatic ICH patients admitted to a tertiary care center, we classified the ICH as CAA, strictly deep ICH/microbleeds, and mixed-location ICH/microbleeds. CSVD burden was quantified using a validated MRI-based score (range: 0-6 points). We created a multivariable (linear mixed effects) model adjusting for age, sex, race, year of inclusion, hypertension, and antihypertensive medication usage to investigate the association of average systolic blood pressure (SBP) during follow-up with cSVD etiology/severity.
Results: 796 ICH survivors were followed for a median of 48.8 months (IQR 41.5-60.4). CAA-related ICH survivors (n = 373) displayed a lower median SBP (138 mmHg, IQR 133-142 mmHg) compared to those of strictly deep ICH (n = 222, 141 mmHg, IQR 136-143 mmHg, p = 0.04), and mixed location ICH/microbleeds (n = 201, 142 mmHg, IQR 135-144 mmHg, p = 0.02). In the multivariable analysis, mixed location ICH/microbleeds (effect: + 3.8 mmHg, SE: 1.3 mmHg, p = 0.01) and increasing cSVD severity (+ 1.8 mmHg per score point, SE: 0.8 mmHg, p = 0.03) were associated with higher SBP in follow-up.
Conclusion: CSVD severity and subtype predicts long-term hypertension control in ICH patients.
Keywords: Cerebral small vessel diseases; Hypertension; Intracerebral hemorrhage; Neuroimaging.
© 2024. Fondazione Società Italiana di Neurologia.
References
-
- Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701. https://doi.org/10.1016/S1474-4422(10)70104-6 - DOI - PubMed
-
- Das AS, Regenhardt RW, Vernooij MW et al (2019) Asymptomatic cerebral small vessel disease: insights from population-based studies. J Stroke 21:121–138. https://doi.org/10.5853/jos.2018.03608 - DOI - PubMed - PMC
-
- Arima H, Tzourio C, Anderson C et al (2010) Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 41:394–396. https://doi.org/10.1161/STROKEAHA.109.563932 - DOI - PubMed
-
- Lioutas VA, Beiser AS, Aparicio HJ et al (2020) Assessment of incidence and risk factors of intracerebral hemorrhage among participants in the Framingham Heart Study between 1948 and 2016. JAMA Neurol:e201512. https://doi.org/10.1001/jamaneurol.2020.1512
-
- Zhang S, Wang Z, Zheng A et al (2020) Blood pressure and outcomes in patients with different etiologies of intracerebral hemorrhage: a multicenter cohort study. J Am Heart Assoc 9:e016766. https://doi.org/10.1161/JAHA.120.016766 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
- 1200-236980/Andrew David Heitman Foundation
- 21SFRN812095/American Heart Association
- NS083711/NS/NINDS NIH HHS/United States
- R01NS114526/NS/NINDS NIH HHS/United States
- 5R01NS096730-04/NS/NINDS NIH HHS/United States
- R01NS103924/NS/NINDS NIH HHS/United States
- U01NS069673/NS/NINDS NIH HHS/United States
- 5R01AG026484/NS/NINDS NIH HHS/United States
- NS083711/NS/NINDS NIH HHS/United States
- R01NS114526/NS/NINDS NIH HHS/United States
- 5R01NS096730-04/NS/NINDS NIH HHS/United States
- R01NS103924/NS/NINDS NIH HHS/United States
- U01NS069673/NS/NINDS NIH HHS/United States
- 5R01AG026484/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
